Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 48 of 48 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/20/18
End: 12/20/25
Due: 12/20/26
Phase: N/A
Priority: Normal
Start: 11/19/18
End: 07/08/19
Due: 07/08/20
Phase: N/A
Priority: Normal
Start: 05/31/04
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 10/31/19
Due: 10/31/20
Phase: N/A
Priority: Normal
Start: 11/29/21
End: 12/13/21
Due: 12/13/22
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 02/10/22
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 07/27/20
End: 05/30/23
Due: 05/30/24
Phase: N/A
Priority: Normal
Start: 03/29/21
End: 11/25/23
Due: 11/25/24
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 11/08/21
End: 06/09/25
Due: 06/09/26
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 03/28/18
Due: 03/28/19
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 03/31/20
Due: 03/31/21
Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 04/30/10
Due: 04/30/11
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 04/03/17
End: 04/03/20
Due: 04/03/21
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 03/31/20
Due: 03/31/21
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 11/07/18
End: 12/31/22
Due: 12/31/23